🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Placebo metered-dose inhaler BID

Found 73 matching trials

New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma

PHASE3

The purpose of this study is to compare the efficacy and safety of the fixe...

Status

Completed

Location

Research Center

Start Date

2006-06

Trial ID

NCT00393952

Treatments Being Tested

Fluticasone propionate/Formoterol fumarate 250/10 Placebo Fluticasone propionate/Formoterol fumarate 100/10 Fluticasone propionate 250 Formoterol fumarate 10

BI 671800 in Asthmatic Patients on Inhaled Corticosteroids

PHASE2

This is a 6 week study to assess the effect of BI 671800 in patients with a...

Status

Completed

Location

1268.16.01004 Boehringer Ingelheim Investigational Site

Start Date

2010-04-20

Trial ID

NCT01103349

Treatments Being Tested

BI 671800 Placebo Montelukast

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma

PHASE3

This is a Phase 3, randomized, placebo-controlled, double-blind,double-dumm...

Status

Completed

Location

Teva Investigational Site 10851

Start Date

2013-12

Trial ID

NCT02031640

Treatments Being Tested

Beclomethasone dipropionate Placebo Albuterol/salbutamol

Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma

PHASE4

The purpose of this study is to determine whether a commonly prescribed ora...

Status

Completed

Location

Multiple Locations

Start Date

2014-09

Trial ID

NCT02338362

Treatments Being Tested

Fluticasone propionate inhaler Saline placebo inhaler

Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg

PHASE2

This is a 16 week multicentre, multinational, randomised, double-blind, dou...

Status

Completed

Location

205.342.43002 Boehringer Ingelheim Investigational Site

Start Date

2006-07

Trial ID

NCT00350207

Treatments Being Tested

Tiotropium bromide Placebo Salmeterol xinafoate

Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)

PHASE2

The aim of this exploratory investigation is to evaluate if the Forced Expi...

Status

Completed

Location

Respiratory Clinical Trials - Heart Lung Centre - Queen Anne Street Medical Centre

Start Date

2008-02

Trial ID

NCT01343745

Treatments Being Tested

BDP/formoterol BDP/formoterol Placebo

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II

PHASE3

The aim of this trial is to evaluate the efficacy and safety of 2.5 and 5 m...

Status

Completed

Location

205.419.01058 Boehringer Ingelheim Investigational Site

Start Date

2010-08

Trial ID

NCT01172821

Treatments Being Tested

placebo placebo placebo tiotropium Respimat® low dose placebo tiotropium Respimat® high dose 50 mcg salmeterol HFA MDI placebo

A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).

PHASE3

This study will investigate the effect of Budesonide, Glycopyrronium, and F...

Status

Completed

Location

Research Site

Start Date

2023-10-24

Trial ID

NCT06067828

Treatments Being Tested

Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate Treatment B: Budesonide and Formoterol Fumarate Treatment C : Placebo

Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma

PHASE2

Study to assess the efficacy and safety of four doses of budesonide inhalat...

Status

Completed

Location

Pearl Therapeutics Study Site

Start Date

2014-04-01

Trial ID

NCT02105012

Treatments Being Tested

BD MDI 320 µg BD MDI 160 µg BD MDI 80 µg BD MDI 40 µg Placebo MDI

Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)

PHASE4

This is a randomized, multi-center, parallel-group, active-controlled, doub...

Status

Completed

Location

Multiple Locations

Start Date

2006-09

Trial ID

NCT00394355

Treatments Being Tested

mometasone furoate dry powder inhaler mometasone furoate dry powder inhaler fluticasone propionate hydrofluoroalkane (HFA)montelukast

Previous Next